ARCHIVES

Conversation with The Cancer Letter: Rosen’s New Role Is Part Of An Evolution Of Administrative Structure at City of Hope

This article is from The Cancer Letter archive.

Vol. 39 No. 41 | November 1, 2013

Download PDF Visit The Full Archive

Related Articles

Organ Systems Meeting Canceled

November 19, 1982

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Modeling Will Be Used For Other Populations

November 26, 2010

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005